Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fabrice Barlesi and Emeline Colomba.
Fabrice Barlesi
Connection Strength
0.477
Emeline Colomba
  1. Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies. Ann Oncol. 2021 11; 32(11):1445-1447.
    View in: PubMed
    Score: 0.240
  2. Severe COVID-19 in patients with hematological cancers presenting with viremia. Ann Oncol. 2021 10; 32(10):1297-1300.
    View in: PubMed
    Score: 0.060
  3. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis. Cell Death Differ. 2021 12; 28(12):3297-3315.
    View in: PubMed
    Score: 0.060
  4. Impact of COVID-19 on healthcare organisation and cancer outcomes. Eur J Cancer. 2021 08; 153:123-132.
    View in: PubMed
    Score: 0.059
  5. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021 03 11; 12(3):258.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.